PEACE: Comparing Chronic Pain Treatment Options
Active, not recruitingNot applicableNCT02979574
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to compare two types of acupuncture with usual care on treating chronic pain. This study has three groups. Two groups will received acupuncture. One group will receive usual standard of care for 12 weeks and then will receive acupuncture. Acupuncture is an ancient Chinese technique of using very thin needles inserted in the skin to treat different symptoms and illness, and to promote healing. Each group will undergo a different method of needle administration.
Study details
- Official title
- Personalize Electro-acupuncture vs. Auricular-acupuncture Comparative Effectiveness
- Interventions
- Procedure: Electro-Acupuncture (EA)
- Procedure: Battle Field Acupuncture (BFA)
- Device: Wait List Control (WLC)
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start date
- 2016-11
- Primary completion
- 2026-11
- Sex
- All
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 7
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * English speaking * Age \>/= 18 years or older * Having musculoskeletal pain, defined as regional (joints, extremities, back, neck) or more generalized (fibromyalgia or chronic widespread pain) * Having a pain rating of 4 or greater in worst pain on a 1-10 numerical rating scale in the preceding week (Patients with a neuropathic component to their pain that involves the extremities or back will be eligible) * Having had pain for at least 3 months and at least 15 days with pain in the preceding 30 days * A diagnosis of cancer with no restrictions placed on type of cancer, other than that patients with metastatic disease will be excluded. Eligibility criteria are not restricted to MSK confirmed biopsy/diagnosis. Participating institution's testing is sufficient for other study sites. * Complete active treatment (surgery, chemotherapy, and/or radiotherapy) at least one month prior to study initiation (patients on continued hormone treatment will not be excluded). Exclusion Criteria: * Have non-musculoskeletal pain syndromes (headache, facial pain, chest pain, visceral abdominal pain) if these are the sole source of pain, but can be present as co-morbid conditions as long as a patient has a primary musculoskeletal pain condition defined s above. * Inflammatory arthritis that require disease modifying drugs (e.g. rheumatoid arthritis) * Phantom limb pain * Patients with a history of metastatic cancer who are not currently NED * Have a pending pain-related VA or social security or worker's comp disability claim by self-report * Have an implanted electronically charged medical device
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02979574